CCM
AMED

Cinctive Capital Management’s Amedisys AMED Stock Holding History

Cinctive Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-89,822
Closed -$8.15M – 312
2024
Q4 		$8.15M Buy
+89,822
New +$8.25M 0.41% 80
2022
Q4 		– Sell
-5,625
Closed -$544K – 386
2022
Q3 		$544K Buy
+5,625
New +$671K 0.02% 380
2021
Q2 		– Sell
-2,613
Closed -$692K – 497
2021
Q1 		$692K Sell
2,613
-5,670
-68% -$1.6M 0.04% 355
2020
Q4 		$2.43M Buy
+8,283
New +$2.12M 0.2% 201

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Cinctive Capital Management's AMED Position: Q1 2025 in Review

Cinctive Capital Management sold out of Amedisys (AMED) in Q1 2025, closing a stake of 89,822 shares — an estimated $8.15M sold.

Cinctive Capital Management first reported a position in AMED in Q4 2020 and held it in 4 quarters. The position peaked at $8.15M in Q4 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Cinctive Capital Management reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 89,822 Amedisys shares in Q1 2025, an estimated $8.15M.
  • Cinctive Capital Management first reported a position in Amedisys in Q4 2020 and held it in 4 quarters.
  • Cinctive Capital Management's Amedisys position peaked at $8.15M in Q4 2024.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Cinctive Capital Management's 13F filing for Q1 2025, filed 15 May 2025.